{"id":540042,"date":"2021-04-22T17:56:02","date_gmt":"2021-04-22T17:56:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=540042"},"modified":"2021-04-22T17:56:02","modified_gmt":"2021-04-22T17:56:02","slug":"chemotherapy-induced-nausea-and-vomiting-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-acacia-pharma-camurus-lp-pharmaceuticals-skye-bioscience-tallc-corporation","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/chemotherapy-induced-nausea-and-vomiting-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-acacia-pharma-camurus-lp-pharmaceuticals-skye-bioscience-tallc-corporation_540042.html","title":{"rendered":"Chemotherapy Induced Nausea and Vomiting Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight| Acacia Pharma, Camurus, LP Pharmaceuticals, Skye Bioscience, TALLC Corporation"},"content":{"rendered":"
\"Chemotherapy<\/a><\/p>\n
\n
Chemotherapy Induced Nausea and Vomiting Pipeline<\/div>\n<\/div>\n<\/div>\n

Chemotherapy Induced Nausea and Vomiting<\/strong> (CINV) are the side effects of cancer chemotherapy that can cause significant negative impacts on patients’ quality of life and on their ability to tolerate and comply with therapy. An estimated 80% of patients with cancer experience chemotherapy-induced nausea and vomiting. It includes emesis and nausea, which can involve a loss of appetite and result in decreased oral intake of fluids and calories. CINV can be classified into 5 types: acute, delayed, anticipatory, breakthrough, and refractory. The pathophysiology of CINV includes both peripheral and central nervous system (CNS) pathways with different mechanisms involved in acute CINV and delayed CINV. Risk factors for developing CINV can be classified as patient-related or treatment-related. Prevention is the primary goal in the management of CINV. The primary alternative for prevention and treatment include 5-HT3 receptor antagonists, NK1 receptor antagonists, and corticosteroids. Other medications used, but to a lesser extent, include dopamine antagonists, benzodiazepines, cannabinoids, and olanzapine.<\/p>\n

DelveInsight’s, “Chemotherapy Induced Nausea and Vomiting Pipeline<\/a> Insight, 2021,”<\/strong> report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Chemotherapy Induced Nausea and Vomiting pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.<\/p>\n

 <\/p>\n

Some of Chemotherapy Induced Nausea and Vomiting Companies are:<\/strong><\/p>\n